Collectionner le produit
Détails du produit
Source
Monoclonal Anti-Human CD45 Antibody, Mouse IgG2a (2E9) is a mouse monoclonal antibody recombinantly expressed from human 293 cells (HEK293), which provides higher batch consistency and long term security of supply.
Antibody Type
Recombinant Monoclonal
Clone
2E9
Isotype
Mouse IgG2a, Kappa
Host Species
Mouse
Reactivity
Human
Immunogen
Purified Human CD45 Protein
Conjugate
PerCP-Cy5.5
Excitation Wavelength: 488 nm
Emission Wavelength: 690 nm
Specificity
This product is a specific antibody specifically reacts with CD45 protein.
Application
Flow Cytometry (Evaluation of the expression of CD45 on Human cells).
Recommended Dilution
1:20
Form
Liquid
Formulation
Supplied as 0.2 μm-filtered solution in PBS (pH 7.4) containing 0.03% ProClin 300 and 0.2% BSA, with trehalose as protectant.
Please contact us for customized product forms or formulations.
Shipping
Liquid product is shipped at blue ice.
Storage
Please protect from light and avoid repeated freeze-thaw cycles.
This product is stable after storage at:
- Store at 2-8 °C for 12 months.
Notices
Product Specific Notices: For research use only.
ACRO Quality Management System
Les clients ont également consulté
Affichage des données
Bioactivity-FACS
Flow cytometric analysis of Jurkat staining with PerCP-Cy5.5 Labeled Monoclonal Anti-Human CD45 Antibody, Mouse IgG2a (2E9) (Cat. No. FABm056-06) at 1:20 dilution (5 μL of the antibody stock solution corresponds to labeling of 1e6 cells in a final volume of 100 µL), compared with isotype control antibody. Percp-cy5.5 signal was used to evaluate the binding activity (QC tested).
Protocol
Avis des utilisateurs Publier un commentaire
Introduction de fond
Progrès de frontière
Progrès du développement médicamenteux- Nom anglais：
Leukocyte common antigen
- Catégorie：
- Nombre de médicaments répertoriés：
0 Détails
- Nombre de médicaments cliniques：
7 Détails
- Étape de développement la plus élevée：
Phase 3 Clinical
Contact Us
Drug Candidate Licensing
